 |
 |
Our site has successfully managed clinical trials for over 20
years. Our research experience includes a broad variety of Infectious
Disease and Hematology-Oncology projects managed in both the
inpatient and outpatient settings. We have participated in clinical
trials with most major pharmaceutical manufacturers and Contract
Research organizations. All trials are managed in accordance
with Good Clinical Practice Guidelines and FDA regulations.
A complete synopsis of our clinical trial activity is available
upon request. |
Our
research interests include phase I, II and III projects involving:
All major Infectious Disease indications
All major Hematology-Oncology indications.
Oncology supportive therapies, such as chemotherapy induced
nausea, and cancer pain
HIV
Hepatitis
Vaccines
Additional infrastructure includes:
Capacity to access central IRBs streamlines and promote
our ability to provide timely data
On site minus 70 degree freezer
Rapid contracts approval process (Usually two-week turn
around time)
Patient database software
Complete Standard Operating Procedures
Study management software
Investigator education, staff education, Quality Assurance
and metrics programs.
Established research network
For more information about our clinical research activities
contact:
Mark Nelson, RPh
Research Director
Northwest Medical Specialties
1624 South I Street #305
Tacoma, WA 98405
Email: mnelson@nwmedicalspecialties.com
|
|
|
